Latest Listings And Ipos News

Lucapa Diamond Company Limited’s shares remain suspended following the appointment of voluntary administrators, highlighting severe financial distress and regulatory breaches.

Constellation Resources Limited is raising approximately $2.52 million through a non-renounceable entitlement offer priced at $0.12 per share, aiming to fund exploration projects in Western Australia and support general working capital.

Unith Ltd has responded to an ASX price query following unusual trading activity, denying undisclosed information and pointing to a successful recent roadshow as a potential factor.

Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.

Oceania Healthcare Limited reported a robust FY25 with a 9.2% rise in sales volume and a 5.8% increase in comprehensive income, underpinned by a successful $500 million debt refinancing and operational enhancements.

West Wits Mining Limited (WWI) has addressed recent spikes in its share price and trading volume, linking the activity to funding developments, a strong gold price, and positive market commentary.

Jupiter Energy has secured extended interest-free terms on its debt and capped repayments as it pursues a dual listing on the Astana International Exchange, aiming to strengthen its financial footing for growth.

Euro Manganese is poised to close a C$11.2 million financing round by late May, fueling progress on its strategic Chvaletice manganese project in the Czech Republic. The move underscores the company's role in Europe's battery materials supply chain.

BetMakers Technology Group reports a strong FY25 trading update, driven by enhancements to its Apollo racing suite and preparations for the GTX wagering platform launch, signaling robust momentum heading into FY26.

Perenti’s African Underground Mining Services has locked in a five-year, A$1 billion contract to provide underground mining services at Ghana’s Obuasi Gold Mine, reinforcing its strategic partnership with AngloGold Ashanti.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.